Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

1.

Sodium intake and cardiovascular health.

O'Donnell M, Mente A, Yusuf S.

Circ Res. 2015 Mar 13;116(6):1046-57. doi: 10.1161/CIRCRESAHA.116.303771.

PMID:
25767289
2.

Insights and perspectives on dietary modifications to reduce the risk of cardiovascular disease.

Baer DJ, Rice Bradley BH, Kris-Etherton P, Mente A, de Oliveira Otto M.

Adv Nutr. 2014 Sep;5(5):553-5.

PMID:
25469391
3.

Sodium and cardiovascular disease.

O'Donnell M, Mente A, Yusuf S.

N Engl J Med. 2014 Nov 27;371(22):2137-8. doi: 10.1056/NEJMc1412113. No abstract available.

4.

Reply to both letters.

Mente A, O'Donnell MJ, Yusuf S.

J Hypertens. 2014 Dec;32(12):2501-3. doi: 10.1097/HJH.0000000000000406. No abstract available.

PMID:
25376254
5.

Evidence relating sodium intake to blood pressure and CVD.

O'Donnell M, Mente A, Yusuf S.

Curr Cardiol Rep. 2014 Oct;16(10):529. doi: 10.1007/s11886-014-0529-9.

PMID:
25297880
6.

A robust method for iodine status determination in epidemiological studies by capillary electrophoresis.

de Macedo AN, Teo K, Mente A, McQueen MJ, Zeidler J, Poirier P, Lear SA, Wielgosz A, Britz-McKibbin P.

Anal Chem. 2014 Oct 21;86(20):10010-5. doi: 10.1021/ac503231u. Epub 2014 Oct 8.

PMID:
25280130
7.

Urinary sodium and potassium excretion, mortality, and cardiovascular events.

O'Donnell M, Mente A, Rangarajan S, McQueen MJ, Wang X, Liu L, Yan H, Lee SF, Mony P, Devanath A, Rosengren A, Lopez-Jaramillo P, Diaz R, Avezum A, Lanas F, Yusoff K, Iqbal R, Ilow R, Mohammadifard N, Gulec S, Yusufali AH, Kruger L, Yusuf R, Chifamba J, Kabali C, Dagenais G, Lear SA, Teo K, Yusuf S; PURE Investigators.

N Engl J Med. 2014 Aug 14;371(7):612-23. doi: 10.1056/NEJMoa1311889. Erratum in: N Engl J Med. 2014 Sep 25;371(13):1267.

8.

Association of urinary sodium and potassium excretion with blood pressure.

Mente A, O'Donnell MJ, Rangarajan S, McQueen MJ, Poirier P, Wielgosz A, Morrison H, Li W, Wang X, Di C, Mony P, Devanath A, Rosengren A, Oguz A, Zatonska K, Yusufali AH, Lopez-Jaramillo P, Avezum A, Ismail N, Lanas F, Puoane T, Diaz R, Kelishadi R, Iqbal R, Yusuf R, Chifamba J, Khatib R, Teo K, Yusuf S; PURE Investigators.

N Engl J Med. 2014 Aug 14;371(7):601-11. doi: 10.1056/NEJMoa1311989.

9.

Blood pressure reduction by reducing sodium intake in the population: one shoe fits all?

Teo K, Mente A.

Curr Opin Cardiol. 2014 Jul;29(4):331-5. doi: 10.1097/HCO.0000000000000079. Review.

PMID:
25029451
10.

The population risks of dietary salt excess are exaggerated.

Mente A, O'Donnell MJ, Yusuf S.

Can J Cardiol. 2014 May;30(5):507-12. doi: 10.1016/j.cjca.2014.02.003. Epub 2014 Feb 13.

PMID:
24786440
11.

Elevated cholesteryl ester transfer protein (CETP) activity, a major determinant of the atherogenic dyslipidemia, and atherosclerotic cardiovascular disease in South Asians.

Rashid S, Sniderman A, Melone M, Brown PE, Otvos JD, Mente A, Schulze K, McQueen MJ, Anand SS, Yusuf S.

Eur J Prev Cardiol. 2015 Apr;22(4):468-77. doi: 10.1177/2047487314528461. Epub 2014 Mar 21.

PMID:
24659026
12.

Validation and comparison of three formulae to estimate sodium and potassium excretion from a single morning fasting urine compared to 24-h measures in 11 countries.

Mente A, O'Donnell MJ, Dagenais G, Wielgosz A, Lear SA, McQueen MJ, Jiang Y, Xingyu W, Jian B, Calik KB, Akalin AA, Mony P, Devanath A, Yusufali AH, Lopez-Jaramillo P, Avezum A Jr, Yusoff K, Rosengren A, Kruger L, Orlandini A, Rangarajan S, Teo K, Yusuf S.

J Hypertens. 2014 May;32(5):1005-14; discussion 1015. doi: 10.1097/HJH.0000000000000122.

PMID:
24569420
13.

Impact of lifestyle factors on fracture risk in older patients with cardiovascular disease: a prospective cohort study of 26,335 individuals from 40 countries.

Khatib R, Yusuf S, Barzilay JI, Papaioannou A, Thabane L, Gao P, Joseph PG, Teo K, Mente A.

Age Ageing. 2014 Sep;43(5):629-35. doi: 10.1093/ageing/afu009. Epub 2014 Feb 18.

PMID:
24554790
14.

Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges.

Working Group on the Summit on Combination Therapy for CVD, Yusuf S, Attaran A, Bosch J, Joseph P, Lonn E, McCready T, Mente A, Nieuwlaat R, Pais P, Rodgers A, Schwalm JD, Smith R, Teo K, Xavier D.

Eur Heart J. 2014 Feb;35(6):353-64. doi: 10.1093/eurheartj/eht407. Epub 2013 Nov 27. Review.

15.

Total and high molecular weight adiponectin and ethnic-specific differences in adiposity and insulin resistance: a cross-sectional study.

Sulistyoningrum DC, Gasevic D, Lear SA, Ho J, Mente A, Devlin AM.

Cardiovasc Diabetol. 2013 Nov 13;12:170. doi: 10.1186/1475-2840-12-170.

16.

Extreme sodium reductions for the entire population: zealotry or evidence based?

Mente A, O'Donnell MJ, Yusuf S.

Am J Hypertens. 2013 Oct;26(10):1187-90. doi: 10.1093/ajh/hpt148. No abstract available.

PMID:
24042546
17.

South Asian Heart Risk Assessment (SAHARA): Randomized Controlled Trial Design and Pilot Study.

Samaan Z, Schulze KM, Middleton C, Irvine J, Joseph P, Mente A, Shah BR, Pare G, Desai D, Anand SS.

JMIR Res Protoc. 2013 Aug 20;2(2):e33.

18.

Causal relationship between adiponectin and metabolic traits: a Mendelian randomization study in a multiethnic population.

Mente A, Meyre D, Lanktree MB, Heydarpour M, Davis AD, Miller R, Gerstein H, Hegele RA, Yusuf S, Anand SS; SHARE Investigators; SHARE-AP Investigators.

PLoS One. 2013 Jun 24;8(6):e66808. doi: 10.1371/journal.pone.0066808. Print 2013.

19.

Mortality benefits from U.S. population-wide reduction in sodium consumption: projections from 3 modeling approaches.

Mente A, O'Donnell MJ, Yusuf S.

Hypertension. 2013 Jun;61(6):e59. doi: 10.1161/HYPERTENSIONAHA.113.01307. Epub 2013 Apr 15. No abstract available.

20.

Salt intake and cardiovascular disease: why are the data inconsistent?

O'Donnell MJ, Mente A, Smyth A, Yusuf S.

Eur Heart J. 2013 Apr;34(14):1034-40. doi: 10.1093/eurheartj/ehs409. Epub 2012 Dec 17. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk